Cleared Traditional

K131287 - CARDIOSLEEVE

K131287 is an FDA 510(k) clearance for CARDIOSLEEVE, manufactured by Rijuven Corp. The device is a Class 2 Cardiovascular device with product code DQD cleared through the Traditional 510(k) pathway after a 49-day FDA review.

K131287 · Rijuven Corp · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jun 2013
Decision
49d
Days
Class 2
Risk

K131287 is an FDA 510(k) clearance for the CARDIOSLEEVE. Classified as Stethoscope, Electronic (product code DQD), Class II - Special Controls.

Submitted by Rijuven Corp (Crofton, US). The FDA issued a Cleared decision on June 24, 2013 after a review of 49 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1875 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K131287

510(k) Number K131287 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 06, 2013
Decision Date June 24, 2013
Days to Decision 49 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 125d · This submission: 49d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQD Device Classification - Class 2, Special Controls

Product Code DQD Stethoscope, Electronic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1875
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQD Stethoscope, Electronic

All 132
Devices cleared under the same product code (DQD) and FDA review panel - the closest regulatory comparables to K131287.
PPA/BT-RB STETHOSCOPE
K132405 · Rnk Products, Inc. · Oct 2013
PCP-USB STETHOSCOPE
K132560 · Rnk Products, Inc. · Oct 2013
SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION
K131044 · Diacoustic Medical Devices (Pty) , Ltd. · Sep 2013
ELECTRONIC STETHOSCOPE
K121144 · Sharp Corporation · Sep 2012
SENSICARDIAC
K121617 · Diacoustic Medical (Pty) · Jul 2012
SENSI
K110704 · Diacoustic Medical Devices (Pty) , Ltd. · Jun 2011
K131287 · CARDIOSLEEVE
Download PDF FDA Summary Rijuven Corp